Brief: Better Therapeutics Announces Positive Primary Endpoint Data From Pivotal Clinical Trial Of BT-001, A Prescription Digital Therapeutic (PDT)

Better Therapeutics

15/03/2022 11:04

March 15 (Reuters) - Better Therapeutics Inc  BTTX.O :
    * BETTER THERAPEUTICS ANNOUNCES POSITIVE PRIMARY ENDPOINT
DATA
FROM PIVOTAL CLINICAL TRIAL OF BT-001, A PRESCRIPTION DIGITAL
THERAPEUTIC (PDT) FOR PATIENTS WITH UNCONTROLLED TYPE 2 DIABETES
    * BETTER THERAPEUTICS INC - SIX-MONTH TRIAL FOR BT-001 IS
ONGOING
AND IS EXPECTED TO BE COMPLETED IN Q2 2022
    * BETTER THERAPEUTICS INC - INTENDS TO FILE A DE NOVO
CLASSIFICATION REQUEST WITH FDA UPON COMPLETION OF BT-001 STUDY

Source text for Eikon:  ID:nBwbFW9DYa 
Further company coverage:  BTTX.O